Further delay for California’s Rx drug tracking system
US drugmakers and wholesalers have welcomed California’s decision to delay for another two years the requirement that all prescription drugs should be tracked electronically, from the beginning to the end of the supply chain, in order to reduce the risk of counterfeit and substandard drugs reaching patients.
Read More




